Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China flag China · Delayed Price · Currency is CNY
79.98
-1.58 (-1.94%)
Nov 17, 2026, 3:00 PM CST

SHA:688578 Revenue

Shanghai Allist Pharmaceuticals had revenue of 1.82B CNY in the quarter ending September 30, 2026, with 33.58% growth. This brings the company's total for the last twelve months to 6.59B, up 38.51% year-over-year. In the year 2025, Shanghai Allist Pharmaceuticals had annual revenue of 5.19B with 45.80% growth. That makes Shanghai Allist Pharmaceuticals the 7,685th largest company in the world by revenue and 1,132nd in China.

Revenue (ttm)
6.59B
Revenue Growth
+38.51%
P/S Ratio
5.46
Revenue / Employee
3.31M
Employees
2,272
Market Cap
35.99B

Revenue Chart

Revenue by Geography

  • China 5.15B 99.3%
  • Overseas 35.00M 0.7%
Fiscal year ended Dec 31, 2025 See the full SHA:688578 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.19B1.63B45.80%
Dec 31, 20243.56B1.54B76.29%
Dec 31, 20232.02B1.23B155.14%
Dec 31, 2022791.00M260.91M49.22%
Dec 31, 2021530.09M529.53M94,409.97%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.